Literature DB >> 25541422

Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3.

Federico Scala1, Salvatore Fusco1, Cristian Ripoli1, Roberto Piacentini1, Domenica Donatella Li Puma1, Matteo Spinelli1, Fernanda Laezza2, Claudio Grassi3, Marcello D'Ascenzo4.   

Abstract

Amyloid β-protein (Aβ) pathologies have been linked to dysfunction of excitability in neurons of the hippocampal circuit, but the molecular mechanisms underlying this process are still poorly understood. Here, we applied whole-cell patch-clamp electrophysiology to primary hippocampal neurons and show that intracellular Aβ42 delivery leads to increased spike discharge and action potential broadening through downregulation of A-type K(+) currents. Pharmacologic studies showed that caspases and glycogen synthase kinase 3 (GSK-3) activation are required for these Aβ42-induced effects. Extracellular perfusion and subsequent internalization of Aβ42 increase spike discharge and promote GSK-3-dependent phosphorylation of the Kv4.2 α-subunit, a molecular determinant of A-type K(+) currents, at Ser-616. In acute hippocampal slices derived from an adult triple-transgenic Alzheimer's mouse model, characterized by endogenous intracellular accumulation of Aβ42, CA1 pyramidal neurons exhibit hyperexcitability accompanied by increased phosphorylation of Kv4.2 at Ser-616. Collectively, these data suggest that intraneuronal Aβ42 accumulation leads to an intracellular cascade culminating into caspases activation and GSK-3-dependent phosphorylation of Kv4.2 channels. These findings provide new insights into the toxic mechanisms triggered by intracellular Aβ42 and offer potentially new therapeutic targets for Alzheimer's disease treatment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A-type K(+) current; Alzheimer's disease; Amyloid-β protein; Caspase; GSK-3; Hippocampal neurons; Intrinsic excitability; KV4.2

Mesh:

Substances:

Year:  2014        PMID: 25541422      PMCID: PMC4801354          DOI: 10.1016/j.neurobiolaging.2014.10.034

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  108 in total

Review 1.  Alzheimer's disease: strategies for disease modification.

Authors:  Martin Citron
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

2.  beta-Amyloid increases dendritic Ca2+ influx by inhibiting the A-type K+ current in hippocampal CA1 pyramidal neurons.

Authors:  Chu Chen
Journal:  Biochem Biophys Res Commun       Date:  2005-11-14       Impact factor: 3.575

3.  Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

Authors:  Igor Klyubin; Dominic M Walsh; Cynthia A Lemere; William K Cullen; Ganesh M Shankar; Vicki Betts; Edward T Spooner; Liying Jiang; Roger Anwyl; Dennis J Selkoe; Michael J Rowan
Journal:  Nat Med       Date:  2005-04-17       Impact factor: 53.440

Review 4.  Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: from animal models to human findings.

Authors:  Marcello D'Amelio; Paolo Maria Rossini
Journal:  Prog Neurobiol       Date:  2012-07-10       Impact factor: 11.685

5.  Expression of olfactory-type cyclic nucleotide-gated channels in rat cortical astrocytes.

Authors:  Maria Vittoria Podda; Lucia Leone; Roberto Piacentini; Sara Cocco; Daniele Mezzogori; Marcello D'Ascenzo; Claudio Grassi
Journal:  Glia       Date:  2012-05-31       Impact factor: 7.452

6.  Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

Authors:  Rimante Minkeviciene; Sylvain Rheims; Marton B Dobszay; Misha Zilberter; Jarmo Hartikainen; Lívia Fülöp; Botond Penke; Yuri Zilberter; Tibor Harkany; Asla Pitkänen; Heikki Tanila
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

7.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

Authors:  Christopher J Phiel; Christina A Wilson; Virginia M-Y Lee; Peter S Klein
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

8.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

Review 9.  Alzheimer's disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory.

Authors:  Igor Klyubin; William K Cullen; Neng-Wei Hu; Michael J Rowan
Journal:  Mol Brain       Date:  2012-07-17       Impact factor: 4.041

10.  A pivotal role of GSK-3 in synaptic plasticity.

Authors:  Clarrisa A Bradley; Stéphane Peineau; Changiz Taghibiglou; Celine S Nicolas; Daniel J Whitcomb; Zuner A Bortolotto; Bong-Kiun Kaang; Kwangwook Cho; Yu Tian Wang; Graham L Collingridge
Journal:  Front Mol Neurosci       Date:  2012-02-15       Impact factor: 5.639

View more
  40 in total

1.  CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability.

Authors:  Wei-Chun J Hsu; Federico Scala; Miroslav N Nenov; Norelle C Wildburger; Hannah Elferink; Aditya K Singh; Charles B Chesson; Tetyana Buzhdygan; Maveen Sohail; Alexander S Shavkunov; Neli I Panova; Carol L Nilsson; Jai S Rudra; Cheryl F Lichti; Fernanda Laezza
Journal:  FASEB J       Date:  2016-02-25       Impact factor: 5.191

2.  GSK3β Modulates Timing-Dependent Long-Term Depression Through Direct Phosphorylation of Kv4.2 Channels.

Authors:  Giuseppe Aceto; Agnese Re; Andrea Mattera; Lucia Leone; Claudia Colussi; Marco Rinaudo; Federico Scala; Katia Gironi; Saviana Antonella Barbati; Salvatore Fusco; Thomas Green; Fernanda Laezza; Marcello D'Ascenzo; Claudio Grassi
Journal:  Cereb Cortex       Date:  2019-05-01       Impact factor: 5.357

3.  PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Wei-Chun J Hsu; Norelle C Wildburger; Sigmund J Haidacher; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya K Singh; Brent C Chesson; Whitney F Franklin; Ibdanelo Cortez; Rovshan G Sadygov; Kelly T Dineley; Jay S Rudra; Giulio Taglialatela; Cheryl F Lichti; Larry Denner; Fernanda Laezza
Journal:  Exp Neurol       Date:  2017-05-15       Impact factor: 5.330

Review 4.  Regulation of intrinsic excitability: Roles for learning and memory, aging and Alzheimer's disease, and genetic diversity.

Authors:  Amy R Dunn; Catherine C Kaczorowski
Journal:  Neurobiol Learn Mem       Date:  2019-08-20       Impact factor: 2.877

5.  Resveratrol Attenuates Aβ-Induced Early Hippocampal Neuron Excitability Impairment via Recovery of Function of Potassium Channels.

Authors:  Hongqiang Yin; Hui Wang; Hui Zhang; Na Gao; Tao Zhang; Zhuo Yang
Journal:  Neurotox Res       Date:  2017-03-30       Impact factor: 3.911

Review 6.  What Happens with the Circuit in Alzheimer's Disease in Mice and Humans?

Authors:  Benedikt Zott; Marc Aurel Busche; Reisa A Sperling; Arthur Konnerth
Journal:  Annu Rev Neurosci       Date:  2018-07-08       Impact factor: 12.449

7.  Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease.

Authors:  Jodi R Paul; Hira A Munir; Thomas van Groen; Karen L Gamble
Journal:  Neurobiol Dis       Date:  2018-03-11       Impact factor: 5.996

8.  Caspase-8 Mediates Amyloid-β-induced Apoptosis in Differentiated PC12 Cells.

Authors:  Min-cai Qian; Jing Liu; Jia-shu Yao; Wei-min Wang; Jian-hong Yang; Li-li Wei; Yue-di Shen; Wei Chen
Journal:  J Mol Neurosci       Date:  2015-02-03       Impact factor: 3.444

9.  Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats.

Authors:  Cheng Chang; Shu-Hui Wang; Li-Na Xu; Xue-Ling Su; Yi-Fan Zeng; Peng Wang; Li-Rong Zhang; Sheng-Na Han
Journal:  J Interv Card Electrophysiol       Date:  2021-02-20       Impact factor: 1.900

10.  Chronic mild stress alters synaptic plasticity in the nucleus accumbens through GSK3β-dependent modulation of Kv4.2 channels.

Authors:  Giuseppe Aceto; Claudia Colussi; Lucia Leone; Salvatore Fusco; Marco Rinaudo; Federico Scala; Thomas A Green; Fernanda Laezza; Marcello D'Ascenzo; Claudio Grassi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.